Donald Edmondson1, Jennifer A Sumner, Ian M Kronish, Matthew M Burg, Linda Oyesiku, Joseph E Schwartz. 1. From the Center for Behavioral Cardiovascular Health, Columbia University Medical Center (Edmondson, Sumner, Kronish, Oyesiku, Schwartz), New York, New York; Section of Cardiovascular Medicine (Burg), Yale University School of Medicine, New Haven, Connecticut; and Department of Psychiatry and Behavioral Science (Schwartz), Stony Brook University, Stony Brook, New York.
Abstract
OBJECTIVE: Posttraumatic stress disorder (PTSD) is associated with incident cardiovascular risk. We tested the association of PTSD with clinic and ambulatory blood pressure (ABP) in a sample of healthy participants and tested ABP reactivity to anxiety as a mechanism by which PTSD may influence blood pressure (BP). METHODS: Participants were originally enrolled during workplace BP screenings at three sites; approximately 6 years (standard deviation = 1.0) later, they completed nine clinic BP assessments within three visits, 1 week apart. Before the third visit, participants were screened for PTSD (≥33 on the PTSD Checklist-Civilian) and depression (Beck Depression Inventory) and then completed 24-hour ABP monitoring with electronic diary assessment of anxiety (0-100) at each awake reading. RESULTS: Of 440 participants, 92 (21%) screened positive for PTSD. In regression models adjusted for depression and demographic and clinical variables, PTSD was associated with greater mean systolic BP (3.8 mm Hg clinic [95% confidence interval {CI}] = 1.1-6.5, p = .006), 3.0 mm Hg awake ABP [95% CI = 0.1-5.9, p = .04], and a nonsignificant 2.1 mm Hg ABP during sleep [95% CI = -1.0 to 5.1, p = .18]). PTSD was associated with greater 24-hour median anxiety (p < .001), and changes in anxiety were positively associated with concurrent systolic ABP (p < .001). ABP reactivity to anxiety was greater in participants with PTSD, which partially explained the association of PTSD with ABP. CONCLUSIONS: PTSD is associated with greater systolic BP, partly because of greater anxiety, and systolic BP reactivity to anxiety throughout the day. Daily anxiety and related BP reactivity may be targets for interventions to reduce the cardiovascular risk associated with PTSD.
OBJECTIVE:Posttraumatic stress disorder (PTSD) is associated with incident cardiovascular risk. We tested the association of PTSD with clinic and ambulatory blood pressure (ABP) in a sample of healthy participants and tested ABP reactivity to anxiety as a mechanism by which PTSD may influence blood pressure (BP). METHODS:Participants were originally enrolled during workplace BP screenings at three sites; approximately 6 years (standard deviation = 1.0) later, they completed nine clinic BP assessments within three visits, 1 week apart. Before the third visit, participants were screened for PTSD (≥33 on the PTSD Checklist-Civilian) and depression (Beck Depression Inventory) and then completed 24-hour ABP monitoring with electronic diary assessment of anxiety (0-100) at each awake reading. RESULTS: Of 440 participants, 92 (21%) screened positive for PTSD. In regression models adjusted for depression and demographic and clinical variables, PTSD was associated with greater mean systolic BP (3.8 mm Hg clinic [95% confidence interval {CI}] = 1.1-6.5, p = .006), 3.0 mm Hg awake ABP [95% CI = 0.1-5.9, p = .04], and a nonsignificant 2.1 mm Hg ABP during sleep [95% CI = -1.0 to 5.1, p = .18]). PTSD was associated with greater 24-hour median anxiety (p < .001), and changes in anxiety were positively associated with concurrent systolic ABP (p < .001). ABP reactivity to anxiety was greater in participants with PTSD, which partially explained the association of PTSD with ABP. CONCLUSIONS:PTSD is associated with greater systolic BP, partly because of greater anxiety, and systolic BP reactivity to anxiety throughout the day. Daily anxiety and related BP reactivity may be targets for interventions to reduce the cardiovascular risk associated with PTSD.
Authors: Marian Abouzeid; Helen L Kelsall; Andrew B Forbes; Malcolm R Sim; Mark C Creamer Journal: J Psychosom Res Date: 2011-09-21 Impact factor: 3.006
Authors: Roland von Känel; Urs Hepp; Bernd Kraemer; Rafael Traber; Marius Keel; Ladislav Mica; Ulrich Schnyder Journal: J Psychiatr Res Date: 2006-08-09 Impact factor: 4.791
Authors: Edward A Walker; Elana Newman; Dorcas J Dobie; Paul Ciechanowski; Wayne Katon Journal: Gen Hosp Psychiatry Date: 2002 Nov-Dec Impact factor: 3.238
Authors: Baojian Xue; Yang Yu; Shun-Guang Wei; Terry G Beltz; Fang Guo; Robert B Felder; Alan Kim Johnson Journal: Am J Hypertens Date: 2019-08-14 Impact factor: 2.689
Authors: Jennifer A Sumner; Adam X Maihofer; Vasiliki Michopoulos; Alex O Rothbaum; Lynn M Almli; Ole A Andreassen; Allison E Ashley-Koch; Dewleen G Baker; Jean C Beckham; Bekh Bradley; Gerome Breen; Jonathan R I Coleman; Anders M Dale; Michelle F Dennis; Norah C Feeny; Carol E Franz; Melanie E Garrett; Charles F Gillespie; Guia Guffanti; Michael A Hauser; Sian M J Hemmings; Tanja Jovanovic; Nathan A Kimbrel; William S Kremen; Bruce R Lawford; Mark W Logue; Adriana Lori; Michael J Lyons; Jessica Maples-Keller; Matig R Mavissakalian; Regina E McGlinchey; Divya Mehta; Rebecca Mellor; William Milberg; Mark W Miller; Charles Phillip Morris; Matthew S Panizzon; Kerry J Ressler; Victoria B Risbrough; Barbara O Rothbaum; Peter Roy-Byrne; Soraya Seedat; Alicia K Smith; Jennifer S Stevens; Leigh Luella van den Heuvel; Joanne Voisey; Ross McD Young; Lori A Zoellner; Caroline M Nievergelt; Erika J Wolf Journal: Front Neurosci Date: 2021-06-23 Impact factor: 4.677